Molecular epidemiology of human cancer

Toxicology Letters

Volumn 102-103, Issue , 1998, Pages 219-225

  Hussain, S Perwez ^a   Harris, Curtis C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer epidemiology; Human cancer; Molecular epidemiology

Indexed keywords

AFLATOXIN B1; PROTEIN P53;

CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONFERENCE PAPER; DNA REPAIR; HUMAN; HYPOXIA; MUTATION; PRIORITY JOURNAL; SUNLIGHT; TUMOR SUPPRESSOR GENE; XENOBIOTIC METABOLISM;

ANIMALS; DNA DAMAGE; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; NEOPLASMS;

EID: 0032436415     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00310-5     Document Type: Conference Paper

References (44)

1. Aguilar, F., Hussain, S.P., Cerutti, P., 1993. Aflatoxin B1 induces the transversion of G →T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 90, 8586-8590.
2. Aguilar, F., Harris, C.C., Sun, T., Hollstein, M., Cerutti, P., 1994. Geographic variation of p53 mutational profile in nonmalignant human liver. Science 264, 1317-1319.
3. Autrup, H., Harris, C.C., Wu, S.M., et al., 1984. Activation of chemical carcinogens by cultured human fetal liver, esophagus and stomach. Chem. Biol. Interact. 50, 15-25.
4. Brash, D.E., 1988. UV mutagenic photoproducts in Escherichia coli and human cells: a molecular genetics perspective on human skin cancer. Photochem. Photobiol. 48, 59-66.
5. Brash, D.E., Rudolph, J.A., Simon, J.A., et al., 1991. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 88, 10124-10128.
6. Bressac, B., Kew, M., Wands, J., Ozturk, M., 1991. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350, 429-431.
7. Denissenko, M.F., Pao, A., Tang, M., Pfeifer, G.P., 1996. Preferential formation of benzo[α]pyrene adducts at lung cancer mutational hotspots in P53. Science 274, 430-432.
8. Dittmer, D., Pati, S., Zambetti, G., et al., 1993. Gain of function mutations in p53. Nat. Genet. 4, 42-46.
9. Forrester, K., Lupold, S.E., Ott, V.L., et al., 1995. Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent. Oncogene 10, 2103-2111.
10. Greenblatt, M.S., Bennett, W.P., Hollstein, M., Harris, C.C., 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
11. Guillouf, C., Rosselli, F., Krishnaraju, K., Moustacchi, E., Hoffman, B., Liebermann, D.A., 1995. p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 10, 2263-2270.
12. Hainaut, P., Soussi, T., Shomer, B., et al., 1997. Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucl. Acids Res. 25, 151-157.
13. Harris, C.C., 1991. Chemical and physical carcinogenesis: advances and perspectives for the 1990's. Cancer Res. 51, 5023s-5044s.
14. Harris, C.C., 1996. The 1995 Walter Hubert lecture - molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumor suppressor gene. Br. J. Cancer 73, 261-269.
15. Hill, A.B., 1965. The environment and disease: association or causation. Proc. R. Soc. Med. 58, 295-300.
16. Hollstein, M., Sidransky, D., Vogelstein, B., Harris, C.C., 1991. p53 mutations in human cancers. Science 253, 49-53.
17. Hsiao, M., Low, J., Dorn, E., et al., 1994. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness. Am. J. Pathol. 145, 702-714.
18. Hsu, I.C., Metcalf, R.A., Sun, T., Welsh, J.A., Wang, N.J., Harris, C.C., 1991. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350, 427-428.
19. I.A.R.C., 1993. Mycotoxins: aflatoxins; studies of cancer in experimental animals. In: Anonymous IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer, Lyon, France, pp. 263-395.
20. Kastan, M.B., Radin, A.I., Kuerbitz, S.J., et al., 1991. Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res. 51, 4279-4286.
21. Kastan, M.B., Zhan, Q., El-Deiry, W.S., et al., 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in Ataxia-Telangiectasia. Cell 71, 587-597.
22. Klein-Szanto, A.J., Iizasa, T., Momiki, S., et al., 1992. A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 89, 6693-6697.
23. Lane, D.P., Benchimol, S., 1990. p53: oncogene or anti-oncogene. Genes Dev. 4, 1-8.
24. Levine, A.J., Momand, J., Finlay, C.A., 1991. The p53 tumour suppressor gene. Nature 351, 453-456.
25. Li, F.P., Garber, J.E., Friend, S.H., et al., 1992. Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J. Natl. Cancer Inst. 84, 1156-1160.
26. Mace, K., Aguilar, F., Wang, J.S., et al., 1997. Aflatoxin B1 induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis 18, 1291-1297.
27. Maltzman, W., Czyzyk, L., 1984. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell Biol. 4, 1689-1694.
28. Nakazawa, H., English, D., Randell, P.L., 1994. UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc. Natl. Acad. Sci. U.S.A. 91, 360-364.
29. Nelson, W.G., Kastan, M.B., 1994. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell Biol. 14, 1815-1823.
30. Park, M., Vande Woude, G.F., 1989. Principles of molecular cell biology of cancer: oncogenes. In: DeVita, V.T., Jr., Hellman, S., Rosenberg, S.A. (Eds.), Cancer. Principles and Practice of Oncology, 3rd ed. J.B. Lippincott Co., New York, pp. 45-66.
31. Perera, F.P., 1996. Molecular epidemiology: insights into cancer susceptibility, risk assessment and prevention. J. Natl. Cancer Inst. 88, 496-509.
32. Perera, F.P., Santella, R., 1993. Carcinogenesis. In: Schulte, P., Perera, F.P. (Eds.), Molecular Epidemiology: Principles and Practices. Academic Press, New York, pp. 277-300.
33. Pfeifer, A.M.A., Cole, K.E., Smoot, D.T., et al., 1993. SV40 T-antigen immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens. Proc. Natl. Acad. Sci. U.S.A. 90, 5123-5127.
34. Ponchel, F., Puisieux, A., Tabone, E., et al., 1994. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. Cancer Res. 54, 2064-2068.
35. Powell, S.N., DeFrank, J.S., Connell, P., et al., 1995. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55, 1643-1648.
36. Puisieux, A., Lim, S., Groopman, J., Ozturk, M., 1991. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res. 51, 6185-6189.
37. Ross, R.K., Yuan, J.M., Yu, M.C., et al., 1992. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 339, 943-946.
38. Shields, P.G., Harris, C.C., 1991. Molecular epidemiology and the genetics of environmental cancer. J. Am. Med. Assoc. 266, 681-687.
39. Soini, Y., Chia, S.C., Bennett, W.P., et al., 1996. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis 17, 1007-1012.
40. Soussi, T., Caron de Fromentel, C., May, P., 1990. Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5, 945-952.
41. Takeshima, Y., Seyama, T., Bennett, W.P., et al., 1993. p53 mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet 342, 1520-1521.
42. Wang, X.W., Gibson, M.K., Vermeulen, W., et al., 1995. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 55, 6012-6016.
43. Wogan, G.N., 1992. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res. 52, 2114s-2118s.
44. Ziegler, A., Jonason, A.S., Leffell, D.J., et al., 1994. Sunburn and p53 in the onset of skin cancer. Nature 372, 773-776.